Corrigendum: Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation [Rheumatology, 55, (2016), (2220-2229)] doi:10.1093/rheumatology/kew325

Giulio Cavalli, Marije Koenders, Vassili Kalabokis, Jihye Kim, Aik Choon Tan, Cecilia Garlanda, Alberto Mantovani, Lorenzo Dagna, Leo A.B. Joosten, Charles A. Dinarello

    Research output: Contribution to journalComment/debatepeer-review

    17 Citations (Scopus)

    Abstract

    The Authors report that the picture originally included in the manuscript as Figure 1A was mistakenly chosen and does not depict the knee joint of a mouse treated with IL-37, but rather with a different molecule, which was coincidently being tested in our laboratory as a treatment for arthritis. The same investigator acquired photographs from separate experiments with the same camera device, and images were mixed up because joint swelling scores were equal and the depicted findings were clinically indistinguishable. The correct Figure 1A is provided hereby and has been corrected online.

    Original languageEnglish
    Pages (from-to)2256
    Number of pages1
    JournalRheumatology (United Kingdom)
    Volume56
    Issue number12
    DOIs
    Publication statusPublished - 2017 Dec 1

    Bibliographical note

    Publisher Copyright:
    © The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved.

    ASJC Scopus subject areas

    • Rheumatology
    • Pharmacology (medical)

    Fingerprint

    Dive into the research topics of 'Corrigendum: Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation [Rheumatology, 55, (2016), (2220-2229)] doi:10.1093/rheumatology/kew325'. Together they form a unique fingerprint.

    Cite this